OpGen Raises $2.1M in Bridge Financing | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – OpGen has raised $2.1 million, the Gaithersburg, Md., firm confirmed today.

The raise, which OpGen disclosed in a document filed with the US Securities and Exchange Commission on Friday, is bridge financing and will be used to support the commercialization of its flagship technology, the Argus Optical Mapping System, a company spokesman told GenomeWeb Daily News today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.